Livongo Health, Inc. (NASDAQ:LVGO) is reporting third quarter financial results on Wednesday 28th October 2020, after market close.
According to analysts surveyed by Thomson Reuters, LVGO is expected to report 3Q20 income of $ 0.05 per share from revenue of $ 98.80 million.
For the full year, analysts anticipate top line of $ 362.24 million, while looking forward to income of $ 0.22 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 290.00 million ~ $ 303.00 million
Click Here For More Historical Outlooks Of Livongo Health, Inc.
Previous Quarter Performance
Livongo Health, Inc. announced income for the second quarter of $ 0.11 per share, from the revenue of $ 91.92 million. According to street consensus, LVGO was expected to report 2Q20 income of $ 0.01 per share from revenue of $ 86.74 million. The top line results outshined analysts by $ 5.18 million or 5.97 percent.
Stock Performance
Shares of Livongo Health, Inc. traded up $ 6.22 or 4.55 percent on Tuesday, reaching $ 142.89 with volume of 1.39 million shares. Livongo Health, Inc. has traded high as $ 144.12 and has cracked $ 137.98 on the downward trend
According to the previous trading day, closing price of $ 142.89, representing a 628.52 % increase from the 52 week low of $ 18.76 and a 9.52 % decrease over the 52 week high of $ 151.05.
The company has a market capital of $ 14.52 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 14th October 2020, downgraded by JPMorgan Chase & Co. to Neutral from Overweight rating, with $ 150.00 target price.
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science.
